Antimicrobial Resistance Practice Questions

Q: The bacterial drug resistance in tuberculosis results from which mechanism?

Mutation. **Explanation:** The development of drug resistance in *Mycobacterium tuberculosis* (MTB) is unique compared to many other bacteria. **Why Mutation is Correct:** In *Mycobacterium tuberculosis*, antimicrobial resistance occurs exclusively due to **spontaneous chromosomal mutations**. Unlike many Gram-negative or Gram-positive bacteria, MTB does not possess horizontal gene transfer mechanisms like plasmids or transposons. These random genetic mutations occur at a predictable frequency (e.g., 1 in $10^6$ to $10^8$ cell divisions). When a patient is treated with inadequate monotherapy or irregular dosing, these resistant mutants are "selected" and survive to multiply, leading to **acquired resistance**. **Why Incorrect Options are Wrong:** * **Transduction & Transformation (A & B):** These are forms of horizontal gene transfer involving bacteriophages and the uptake of free DNA, respectively. While common in bacteria like *Staphylococcus* or *Streptococcus*, they have no documented role in clinical drug resistance in MTB. * **Plasmid-mediated resistance (C):** Plasmids are extrachromosomal DNA elements frequently responsible for multi-drug resistance in Enterobacteriaceae (e.g., via R-plasmids). *M. tuberculosis* does not harbor resistance-carrying plasmids. **High-Yield Clinical Pearls for NEET-PG:** * **Multi-Drug Resistant TB (MDR-TB):** Defined as resistance to at least **Isoniazid (H)** and **Rifampicin (R)**. * **Genetic Targets:** * **Rifampicin resistance:** Mutation in the **rpoB** gene (beta subunit of RNA polymerase). * **Isoniazid resistance:** Mutation in **katG** (most common) or **inhA** genes. * **DOTS Strategy:** The primary reason for using "Multi-Drug Therapy" in TB is to prevent the selection of these spontaneous resistant mutants. The probability of a bacilli developing simultaneous mutations to two drugs is mathematically negligible ($10^{-6} \times 10^{-8} = 10^{-14}$).

Q: How does Staphylococcus aureus become resistant to methicillin?

Transpeptidase. ### Explanation **1. Why Transpeptidase is Correct:** Methicillin resistance in *Staphylococcus aureus* (MRSA) is primarily mediated by the acquisition of the **mecA gene**. This gene encodes a modified **Penicillin-Binding Protein (PBP2a)**. PBPs are essentially **transpeptidases**, enzymes responsible for cross-linking the peptidoglycan layers of the bacterial cell wall. While standard PBPs are inhibited by beta-lactam antibiotics (like methicillin or oxacillin), the modified transpeptidase (PBP2a) has a **low affinity** for these drugs. This allows the bacteria to continue cell wall synthesis even in the presence of the antibiotic, leading to resistance. **2. Why Other Options are Incorrect:** * **Option A (Heat shock protein):** These are molecular chaperones that help in protein folding and stress response; they do not mediate antibiotic resistance in Staphylococci. * **Option B (Protein A):** This is a key virulence factor of *S. aureus* that binds to the **Fc portion of IgG**, preventing opsonization and phagocytosis. It is not involved in drug resistance. * **Option C (Protein C):** This is a host (human) anticoagulant protein that inactivates Factors Va and VIIIa. It has no role in bacterial physiology. **3. High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Test:** The detection of the **mecA gene** by PCR is the gold standard for identifying MRSA. * **Phenotypic Screening:** Cefoxitin disk diffusion is preferred over methicillin/oxacillin disks for screening MRSA in labs because it is a better inducer of the mecA gene. * **Drug of Choice:** **Vancomycin** is the traditional drug of choice for MRSA. For VRSA (Vancomycin-resistant), Linezolid or Daptomycin are used. * **Exceptions:** MRSA is resistant to all beta-lactams **except** 5th generation cephalosporins (e.g., **Ceftaroline**).

Q: Hain test is used for:

Detection of both rifampicin and INH resistance. **Explanation:** The **Hain test**, also known as the **GenoType MTBDRplus** assay, is a commercial Line Probe Assay (LPA) used for the rapid molecular detection of drug resistance in *Mycobacterium tuberculosis*. **1. Why Option C is Correct:** The Hain test utilizes PCR and reverse hybridization to identify specific mutations in the MTB genome. It simultaneously targets: * **rpoB gene:** Mutations here confer resistance to **Rifampicin**. * **katG and inhA promoter genes:** Mutations here confer resistance to **Isoniazid (INH)**. Because it detects resistance to both primary bactericidal drugs, it is the gold standard for the rapid diagnosis of Multidrug-Resistant TB (MDR-TB). **2. Why Other Options are Incorrect:** * **Options A & B:** These are incomplete. While the test does detect resistance to these drugs individually, its clinical utility lies in its ability to screen for both simultaneously to identify MDR-TB. * **Option D:** The Hain test (MTBDRplus) only covers Rifampicin and INH. Resistance to other first-line drugs (Pyrazinamide, Ethambutol) or second-line drugs (Fluoroquinolones, Aminoglycosides) requires different assays, such as the **MTBDRsl** (Second Line) test. **High-Yield Clinical Pearls for NEET-PG:** * **Turnaround Time:** Provides results within 24–48 hours, much faster than culture-based DST. * **Prerequisite:** It can be performed on smear-positive sputum samples or culture isolates. * **Key Genes to Remember:** * *rpoB* = Rifampicin * *katG* (high-level) & *inhA* (low-level) = INH. * **NTEP Protocol:** In India, LPA is a key component of the Programmatic Management of Drug-Resistant TB (PMDT).

Q: Which of the following drugs should not be used to treat Klebsiella infection?

Ampicillin. ### Explanation The correct answer is **Ampicillin**. **1. Why Ampicillin is the correct answer:** *Klebsiella pneumoniae* possesses a **constitutive (intrinsic) resistance** to Ampicillin and Amoxicillin. This is due to the presence of chromosomally mediated **SHV-1 beta-lactamase** enzymes that hydrolyze these penicillins. Therefore, Ampicillin is clinically ineffective against *Klebsiella* species regardless of the strain's sensitivity profile in the lab. **2. Analysis of Incorrect Options:** * **B. Amikacin:** This is an Aminoglycoside often used as part of a combination therapy for serious Gram-negative infections, including *Klebsiella*. * **C. Imipenem:** A Carbapenem that remains one of the most potent drugs against *Klebsiella*, particularly for Extended-Spectrum Beta-Lactamase (ESBL) producing strains. However, resistance is rising due to Carbapenemases (KPC). * **D. Tigecycline:** A Glycylcycline used as a "reserve drug" for Multi-Drug Resistant (MDR) *Klebsiella*, including Carbapenem-Resistant Enterobacteriaceae (CRE). **3. High-Yield Clinical Pearls for NEET-PG:** * **Intrinsic Resistance:** Always remember that *Klebsiella* is naturally resistant to Ampicillin. Similarly, *Proteus mirabilis* is intrinsically resistant to Nitrofurantoin, and *Pseudomonas* is resistant to many common antibiotics like Tigecycline. * **ESBL Production:** *Klebsiella* is a frequent producer of ESBLs, which confer resistance to 3rd generation Cephalosporins (Ceftriaxone, Ceftazidime). The drug of choice for ESBL-producing *Klebsiella* is a **Carbapenem**. * **Morphology:** On MacConkey agar, *Klebsiella* produces large, mucoid, pink colonies (Lactose Fermenter) due to its prominent polysaccharide capsule.

Q: Enzyme inactivation is the main mode of resistance to which class of antibiotics?

Aminoglycosides. **Explanation** The primary mechanism of resistance to **Aminoglycosides** (e.g., Gentamicin, Amikacin) is the production of **Aminoglycoside Modifying Enzymes (AMEs)**. These bacterial enzymes (phosphorylases, adenyltransferases, and acetyltransferases) modify the antibiotic molecule, preventing it from binding to the 30S ribosomal subunit. While other mechanisms like efflux pumps and ribosomal mutations exist, enzyme inactivation is clinically the most significant and common mode of resistance. **Analysis of Incorrect Options:** * **Quinolones (e.g., Ciprofloxacin):** Resistance is primarily due to **target site mutations** in DNA gyrase (*gyrA*) and Topoisomerase IV (*parC*), or through decreased permeability and efflux pumps. * **Rifamycins (e.g., Rifampicin):** Resistance occurs almost exclusively through **mutations in the *rpoB* gene**, which encodes the beta-subunit of bacterial RNA polymerase, altering the drug's binding site. * **Glycopeptides (e.g., Vancomycin):** Resistance (seen in VRE) is due to **target site modification**, where the terminal D-Ala-D-Ala of the peptidoglycan precursor is replaced by D-Ala-D-Lac or D-Ala-D-Ser, reducing the drug's affinity. **High-Yield Clinical Pearls for NEET-PG:** * **Amikacin** is often the most resistant aminoglycoside to these enzymes because its side chain protects it from many AMEs. * **Beta-lactams** also utilize enzyme inactivation (Beta-lactamases) as a major mechanism, but among the options provided, Aminoglycosides are the classic example. * **Mnemonic for Aminoglycoside Resistance:** **A**cetylation, **P**hosphorylation, **A**denylation (**APA** enzymes).

Question 1

The bacterial drug resistance in tuberculosis results from which mechanism?

Accepted Answer

Mutation

Answer

Transduction

Answer

Transformation

Answer

Plasmid mediated resistance

Question 2

How does Staphylococcus aureus become resistant to methicillin?

Accepted Answer

Transpeptidase

Answer

Heat shock protein

Answer

Protein A

Answer

Protein C

Question 3

Hain test is used for:

Accepted Answer

Detection of both rifampicin and INH resistance

Answer

Detection of INH resistance only

Answer

Detection of rifampicin resistance only

Answer

Detection of resistance to all first-line anti-tuberculosis drugs

Question 4

Which of the following drugs should not be used to treat Klebsiella infection?

Accepted Answer

Ampicillin

Answer

Amikacin

Answer

Imipenem

Answer

Tigecycline

Question 5

Enzyme inactivation is the main mode of resistance to which class of antibiotics?

Accepted Answer

Aminoglycosides

Answer

Quinolones

Answer

Rifamycins

Answer

Glycopeptides

Antimicrobial Resistance — MCQs

Antimicrobial Resistance — MCQs

On this page

Practice by Chapter

Want unlimited practice?